Clinical Trials Arena Weekly Update 27.10.2023
Clinical Trials Arena
The leading site for data driven news in the Clinical Trial industry. Part of GlobalData.
Here is your weekly round up of the biggest news, stories and analysis in the Clinical Trials Industry.
Precision medicine: Promising future as AI, biomarkers and technology bolster the field
In our latest feature we look at how technology is having a significant impact in healthcare and how its impact in the development of precision medicine is set to be huge. Read More
Antimicrobial resistance threatens to set modern medicine back decades
The United Nations predicts annual worldwide deaths due to drug-resistant bacteria will exceed 10 million by 2050. Read More
Pfizer and BioNTech post early win for combination Covid-19/flu vaccine
Pfizer and BioNTech SE have reported positive results from the Phase I/II clinical study evaluating a combination vaccine for influenza and Covid-19. Read More
CpHI Europe: Pharma companies fail to engage patients early in drug development
Experts discuss how pharma companies need to consider patient centricity earlier in their development plans. Read More
GlobalData R&A lead says “virtual clinical trials are here to stay”
Data showing the sharp rise in virtual clinical trials has been detailed to delegates at the CTS Copenhagen conference explaining how virtual trials have quadrupled since 2019. Read More
Annovis looks to advance pivotal Alzheimer’s and Parkinson’s drug studies
Annovis Bio, Inc. is working to progress its lead oral drug for Alzheimer’s disease (AD) and Parkinson’s disease (PD) studies as two trials evaluating the therapy’s potential reach the tail-end of their recruiting goals, said CEO Maria L. Maccecchini, PhD . Read More
Recommended by LinkedIn
GSK’s RSV vaccine Arexvy effective in adults aged 50-59 years
GSK has released new preliminary data showing that its respiratory syncytial virus (RSV) vaccine Arexvy met primary endpoints in a Phase III trial in adults aged 50 to 59 years. Read More
Partner Content
How the life sciences sector can defend against the top five data protection challenges
Pharma and healthcare organisations use patient data to deliver personalised treatments and efficient care, but the digitalisation of the industry raises new privacy and cybersecurity concerns. Cassie explores how the life sciences industry can address these challenges to create a secure and compliant health data ecosystem. Read More
Contact Us
For Editorial Enquires - clinicaltrialsarena@globaldata.com
For Advertising & Content Marketing Enquires - josh.jones@globaldata.com